MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA - PowerPoint Presentation

Slide1

MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA

.

DR OMOLO

THE CLINIC GROUP

Slide2

NCD Report May 2015

A total of 183 cancer related deaths occurred in Swaziland as reported by

t

he national prevention and control of non-communicable diseases programme annual report 2014

Slide3

I screened a total of 75 ladies who presented in my practice, the youngest being

20

years and oldest 76 years. 54 ladies had normal results and 21 abnormal results, thus 22.6% of ladies required additional evaluation.

Slide4

The results were categorized as: 54 normal;1 ASCUS;1 AGCUS; 2 LSIL; 2 LSIL-HSIL;13 HSIL; 2 carcinoma

Slide5

74 ladies accepted to be tested for HIV;52 ladies were HIV negative(69.3%);22 ladies tested HIV positive(29.3%) and 1 lady declined to be tested(0.01%)

Slide6

Lesions in the background of HIV

: 1 lady with normal findings declined screening; among 52 who were HIV negative 8(15.3%) had abnormal smear results; among 22 who were HIV positive 13 (59%) had abnormal results. Being HIV makes the lady 4 times likely to have abnormal CIN.

Slide7

CIN

CIN

₌ Cervical

intraepithelial neoplasia, is the term now used to encompass all epithelial abnormalities of the cervix. These abnormalities are confined to the epithelium and are regarded as preinvasive lesions. In average cervical

preinvasive

lesions

precedes

cervical cancer by 15.6 years (range 3-20 years).

CIN is asymptomatic.

Slide8

Screening

Being asymptomatic, CIN are identified through screening. The standard

screening test

is cervical cytology. Eitheri) Papanicolaou (Pap) smear Ii) Liquid based cytology,(thin layer preparation of cervical specimen) is a modification of pap smear.Cervical cytology selects

those women who should have further

evaluation

and ≈

7-10% of women who are screened require additional evaluation.

Terminology

for reporting cervical cytology

is

standardized by the Bathesda

system.

Lesions are broadly divided

into two subgroups:

1)Mild

atypical cellular changes in the lower third of the epithelium

referred to as

l

ow-grade

cervical intraepithelial

neoplasia(CIN1= ASCUS

, Atypical squamous cell cannot exclude high grade squamous intraepithelial lesion, LSIL)

2)Moderate

and

severe

atypical cellular changes confined to the basal two thirds and full thickness of the

epithelium referred to as

h

igh-grade

cervical intraepithelial neoplasia (CIN II–III/CIS)

Slide9

Diagrammatic illustration of CIN

Slide10

Screening guidelines

a)With cytology (Pap smear or LBC) every 2 years between ages 21-29 years, then cytology every 3 years between ages 30-65 years provided that the last 3 reports are normal.

b) With cytology & HPV-DNA typing every 3 years after 30 years, discontinue between 65-70 years in negative screened women in the last 10 years.

c) More frequent screening is advised in high risk group e.g. those with HIV; those who are immunosuppressed-transplant patients or those on prolonged steroids and those who have been treated for CIN II, CIN III, or cervical cancer.

Slide11

Role of human papillomavirus

Sexual activity has been consistently implicated as the dominant risk factor for occurrence of cervical cancer. These lesions are almost non-existent in women who have not had any sexual relationships.

And t

he major factor causing these lesions is the infection with the human papilloma virus .HPVI association is so strong that most other behavioural, sexual and socioeconomic co-variables are all dependent upon HPV infection and do not hold up as independent risk factors

.

Slide12

12

Normal

epithelium

Basement membrane

Basal (stem)

cells

Parabasal

cells

Squamous

layer

Mature

squamous

layer

Infected

epithelium

Cervical canal

HPV infects basal layer of cervical epithelium

HPV lifecycle in the cervix is confined to the epithelium

Adapted from Frazer IH.

Nat Rev Immunol

2004;

4:

46–54.

Virus particles are assembled and virus released

Virus uses host cell to replicate viral DNA and express virally encoded proteins

Note that this diagram depicts infection of the squamous epithelium not columnar epithelium.

Slide13

Sequelae of acute infection

Once

the epithelium is

infected. 3 clinical scenarios may result :1) Latent infection without any manifestations, what is seen in over 90% of infected women

2) Active

infection where HPV undergoes vegetative replication, but is

not

integrated into the host cell genome (will results in

low grade lesions)

3) Neoplastic

transformation in which HPV integrates into the human

genome (results in HSIL

and cancer). 2 major factors

i)

Infection with

high

risk HPV subtypes(16,18,31,33,35,45,59)

and ii)

Persistence

factors

such as

smoking, sexual exposure and immunosuppression as predisposing factors to neoplastic transformation.

Slide14

Natural history of CIN(cervical carcinogenesis

)

REGRESS

HSIL/CIS

CA

ASCUS IN 24 MONTHS

68%

7.3%

0.25%

LOSIL IN 24 MONTHS

47%

21%

0.15%

HSIL IN 24 MONTHS

35%

 

1.44%

LOSIL IN 20 YEARS

60%

10%

1%

HSIL IN 20 YEARS

33%

 

12%

Slide15

Burd EM.

Clin Microbiol Rev

2003;

16:

1

–

17;

Solomon D,

et al. JAMA

2002;

287:

2114

–

2119.

Low-grade squamous intraepithelial lesion (ASCUS/LSIL)

High-grade squamous intraepithelial lesion (HSIL)

Invasive

carcinoma

Time

Years

Months

Normal

epithelium

HPV infection

koilocytosis

CIN1

CIN2

CIN3

Regression

* With increasing probability of viral DNA integration.

CIN = cervical intraepithelial neoplasia; ASCUS = atypical squamous cells of undetermined significance.

Progression*

HPV cervical disease: cervical carcinogenesis

(Progression

&

regression)

Slide16

II Treatment

Given the natural history of CIN, the goal of treatment is to

prevent possible progression to invasive cancer while

avoiding overtreatment of lesions that are likely to regress

Slide17

Diagnosis

Being asymptomatic,

screening

is our only option of making a diagnosis .Cytology(pap smear & LBC) (remains an art - as many as 30% of new cases of cervical cancer each year are the result of false-negative test results).To improve accuracy of screening ,it is best, where available to combine HPV DNA testing with cytology for ladies above 30 years

Slide18

Colposcopy

As

an adjunctive technique to cytology

Colposcope is designed to study the genital epithelium. It allows the entire cervix to be carefully examined at low power, with emphasis on the details of the transformation zone. Findings sought for include:-Keratosis(represents HPV infection, chronic trauma or scarring)-Acetowhite (represent higher nuclear/cytoplasm ratio-more distinct in CIN)-Borders(sharper & smoother of Acetowhite lesions are seen in HSIL)

-Surface contour(uneven contours seen with warts,cauliflower,nodular or ulcer with cancer)

-Color

-Lugol’s

uptake(neoplastic

cells lack glycogen hence do not turn brown

)

-Vascular

pattern(neoplastic

epithelium produces angiogenic factors VEGF which results in neovascularisation).

-inflammation (when present make exam difficult and must be treated before colposcopy)

Slide19

CIN1

Cytology

Mild dysplasia

Changes to shape and size of cells

Changes to size and appearance of cell nuclei

Koilocytosis

Appearance on colposcopy

Acetowhite reaction

More transient

Mild translucent acetowhite

Margins

Feathered, flocculated and geographic

Indistinct

Irregular

Surface contours flat

No abnormal vessels

Reduced iodine uptake, light yellow

Normal, healthy cervix

1

1. Image used with permission from Professor Achim Schneider.

2. Image used with permission from

Dr Alejandro Ortiz de la Peña

.

Cervix with CIN1

Mild aceto-white epithelium

2

Slide20

CIN2

Cytology

Moderate dysplasia

More abnormal nuclei, especially in immature cells

Appearance on colposcopy

Acetowhite reaction

Dull, oyster-white colour

Surface contour

Flat or raised

Margins

Straight

Vascular pattern

Mosaic

Punctation

Iodine uptake

Reduced, bright yellow

Cervix with CIN2

Image used with permission from Professor Muhieddine Seoud.

Moderate aceto-

white epithelium

Slide21

CIN3

Cytology

Severe dysplasia

Severe nuclear abnormality in immature basal cells

Keratinization or cornification may be present at surface or in isolated cells inside epithelium

Appearance on colposcopy

Acetowhite reaction

Dull, denser white, not shiny

Remains for longer time

Surface contour

Flat or raised

Margins

Sharp and distinct

Internal margins possibly present with LSIL

Vascular pattern

Coarse punctation and or mosaic

Wide intercapillary distance

Iodine uptake

Rejects iodine

Cervix with CIN3

Image used with permission from

Dr Alejandro Ortiz de la Peña

.

A dense opaque acetowhite area with coarse mosaics

Slide22

Treatment overview techniques

Treatment

decisions are

based upon diagnostic results from histologic examination, preferably colposcopically directed biopsies where available.

Slide23

Low grade lesions(HPV &CIN 1)

These have

a high spontaneous remission rate and that most lesions will regress within a 2-year follow-up period.

Options for the management include Conservative treatment by ablation or Close follow-up without treatment (observation,

expectant management

) by

surveillance Pap smears every 4–6

months

or HPV testing at 12 months

for 2 years then every 6 months if low-grade changes persist.

Women

can return to regular screening only if consecutive normal Pap smear results are obtained.

If

the lesion progresses during the surveillance period it should be treated.

Treatment

is only recommended:  

If

CIN 1 persists for >24 months

For

an occasional anxious patient who may elect to be treated to relieve her anxiety.

In

a patient at very high risk for loss to follow-up.

Slide24

High grade lesions /(CIN 2, 3; CIS)

These patients require

treatment.

Ablative techniques are only appropriate when invasive cancer has been excluded .1. If the lesion is small, the entire lesion is well-visualized, and there is no endocervical disease, then cryotherapy can be used for the management of high-grade lesions. Cryotherapy is not recommended for large, complex high-grade lesions. 2.Large lesions are treated with:i) The LEEP procedure (

widely

available and

easy).

The main advantage of the LEEP is that there is a histologic specimen for evaluation. Two

disadvantages

for

it’s use,

include the removal of excessive amounts of tissue and the danger of overtreatment.

ii) CO

2

laser

vaporization(if available) allows

greater precision in the destruction of abnormal tissues.

It’s

main advantage

is

in the treatment of lesions wide on the transformation zone and in situations in which the treatment of cervical dysplasia is concurrent with laser treatment of dysplastic lesions of the vagina and vulva.

Slide25

High grade lesions /(CIN 2, 3; CIS)

Excisional therapy(cervical conization)

:

is recommended for women with cytological findings potentially associated with high-grade lesions. These allow further histologic study. Cervical conization (also known as cone biopsy) refers to the excision of a cone shaped portion of the cervix surrounding the endocervical canal and including the entire transformation zone.Techniques for cervical conization include cold-knife conization, laser conization, and the use of the LEEP as cone. In general, either ablative or excisional treatments of CIN are successful.

Slide26

Hysterectomy 

Hysterectomy is not the treatment of choice

But valid

indications include:1. When conization specimen margins are positive for HSIL,(completed childbearing and expected poor compliance with follow-up). Though, the treatment of choice is close clinical follow-up or, in select cases, reexcision to exclude an invasive cancer instead of hysterectomy. Hysterectomy should generally be reserved for those in whom a repeat excisional procedure is not technically feasible or where the cervix and vagina are scarred in a way that severely compromises the reliability of cervical cytology and close clinical follow-up.

2. Presence

of coexistent gynaecologic conditions requiring hysterectomy such as symptomatic uterine fibroids

3. Patient

request and persistent or recurrent HSIL.

Slide27

III Preinvasive cervical lesions in HIV -setting

In 1993, the CDC designated high grade lesions as conditions defining a stage of early symptomatic HIV infection and invasive cervical carcinoma as an AIDS defining condition.

The

incidence of CIN is 4-5 times higher among HIV-infected compared to HIV-negative women. And the risk of cervical cancer among HIV-infected women is 5-7 fold the risk in the HIV-negative women.HIV infected women especially those with low CD4 counts have the highest prevalence of HPV infection,habor high risk HPV types and are at high risk for persistence of cervical HPV infection

Slide28

How then do one manage CIN in these setting:

The appropriate management of CIN, timing and method of follow up is still unfortunately largely unknown.

Guiding data is not available and therefore

close follow up is essential.This is study item for one to look into in order to design treatment of CIN for this category.

Slide29

Low grade lesions

U

nderstanding

the natural history of such lesions in HIV infected women is necessary in order to determine the treatment approach. No satisfactory data exist and therefore same recommendation of expectant management of women with biopsy confirmed CIN1 and satisfactory colposcopy. The use of HAART has been associated with increased rates of regression and decreased rates of recurrence in HIV infected women. Based on this, HIV infected women using HAART with low viral loads and stable CD4 levels may be managed similar to non-HIV infected women.

Slide30

High grade lesions

Excision and ablation

are both accepted treatment modalities for HIV infected women with satisfactory colposcopic examinations.

If colposcopy is not available or not satisfactory, then ablative treatment is unacceptable because histopathological examination of the nonvisualized tissue is required to exclude the presence of occult cancer. A diagnostic and therapeutic excisional procedure is performed in these cases. Excision is also recommended for patients with recurrent disease after ablation.The success rate of these modalities in HIV-negative women is over 90% but is lower in HIV-infected women. Persistence and recurrent disease is also more common. One factor that contributes to the poorer treatment outcome is incomplete excision or ablation of CIN. The margin status of the tissue specimens is critical.

Slide31

Medical therapy

Because of the results of standard excisional therapy are not better as compared to those in HIV-negative women, use of primary or adjuvant medical therapy to improve treatment outcomes has been investigated.

Topical –fluorouracil (5-FU) is an effective prophylactic agent for immunosuppressed women with CIN

. 6 months of topical application of 2g of 5% cream biweekly is recommended as adjunctive therapy to excision/ ablation procedures for high grade lesionsHAART- is associated with regression of CIN. It lends support to the recommendation that CIN is a relative indication for HAART.

Slide32

Follow-up

HIV-infected women with CIN should be advised that recurrence is more frequent than in the general

population.

Cancer can also develop rapidly in HIV infected women (3.2 vs. 15.7 years). Therefore, these women require close monitoring after treatment. Hysterectomy is an option for recurrent CIN in women not desirous of fertility.The recommendation is monitor with both cervical cytology, colposcopy, with liberal use of biopsy, at least 3 month intervals for an indefinite period of time.

Slide33

Surveillance

Surveillance after treatment should be designed to identify women with treatment failures as well as those in whom recurrent CIN develops.

Persistence

of a lesion (incomplete treatment or recurrent CIN)seen in 1–20% of cases). Factors associated with persistent or recurrent disease include age older than 40 years, glandular involvement, large lesions, and positive treatment margins, HIV coinfection

.

Serial

repeat Pap smears performed at

3–6month

intervals for several years

will identify

persistent or recurrent CIN.

The use of HPV testing is particularly

attractive in post treatment follow up. The

majority of women with recurrent CIN have persistent positive high-risk HPV tests while recurrence is rare in the face of negative follow-up HPV testing.

Slide34

Surveillance

When several consecutive smears are within normal limits and/or a repeat high-risk HPV test is negative for persistent infection, the patient can return to regular screening.

If

recurrent dysplasia is noted on follow-up Pap, the patient should undergo repeat colposcopy. Recurrent dysplasia documented by directed biopsy should be treated with cold-knife conization or LEEP conization. In cases in which invasive carcinoma has been excluded and fertility is not desired, hysterectomy can be considered.

Care

should be taken to evaluate for vaginal involvement in these recurrent cases, because failure to treat concomitant vaginal dysplasia may result in persistently abnormal smears.

Slide35

Treatment

complications

Cryotherapy

, CO2 laser therapy, and LEEP excision all have excellent success rates, each is associated with some risk of complication.Cryotherapy has the lowest rates of bleeding and infection but has higher failure rates when treating large lesionsBoth laser and LEEP

may be associated with bleeding, but complication rates are low. Post treatment bleeding occurs in 2–7% of LEEP procedures, with bleeding significant enough to result in hospitalization in only 1–2

%.

Long-term morbidity of these procedures is minimal

.

i)

Scarring severe enough to result in unsatisfactory colposcopic examination occurs in 1.3% to 9% of patients undergoing LEEP and 1.3–3.8% have cervical stenosis after the procedure. The risk of cervical stenosis and its resulting hydro-hematometra is much higher in women who have a LEEP that extends 1.5 cm or more into the endocervical canal and in women who have had previous ablative therapy.

Slide36

Treatment

complications

Ablative techniques such as cryotherapy or CO

2 laser for treatment of dysplasia have less impact on future fertility than surgical conization. Several studies have addressed the impact of LEEP procedures on subsequent pregnancy outcome with favourable results. Two case–control studies showed that compared with controls, patients with a history of a cervical LEEP procedure had no higher rate of prematurity or cesarean delivery. Impact on fertility is more difficult to obtain, but no clear association between decreased fertility and LEEP procedures has been demonstrated. In general, excision depth should be limited to less than 7–10 mm in patients desiring to preserve fertility, and repeat excisions should be performed with caution, and for good reason, in young patients.

Slide37

Our duty/ role

Sex the all important risk factor is rampant in the human race.

And

CIN exists, more so amongst the HIV positive population. CIN is asymptomatic and therefore we should look for it when an opportunity presents itself, remember the screening guidelines and enquire with your client and recommend screening if it is due.The burden for us in the fight against cervical cancer mainly is in prevention. We are completely helpless when it comes to treating cervical cancer. We should advocate for

screening

a

s a secondary preventive method and

HPV vaccination to prevent HPVI and with it, the development of CIN and

attempt to instill good morals amongst the at risk groups.

Vaccination have almost eradicated over 27 infections.

I leave you with the disease human race have benefited from vaccines.

Slide38

To date, vaccines have been used very successfully to prevent 27 major diseases

Anthrax

Cholera

Diphtheria

Haemophilus influenzae type b

Hepatitis A

Hepatitis B

Influenza

Japanese

encephalitis

Measles

Meningococcal

Mumps

Pertussis

Pneumococcal

Polio

Rabies

Rubella

Smallpox and vaccinia

Tetanus

Tick-borne encephalitis

Tuberculosis

Typhoid

Varicella

Yellow fever

Human papillomavirus

B

enefits of vaccination

Slide39

END

THANK YOU.